Illumina | ILMN - Net Income

Stock Price
127.88
Daily Change
2.44 1.95%
Monthly
1.33%
Yearly
65.33%
Q2 Forecast
125.14

Illumina reported $334M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Boston Scientific USD 672M 83M Dec/2025
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -146M 281M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Illumina USD 334M 184M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD 225.21M 76.29M Dec/2025